- Home
- COCP vs NNVC Comparison
COCP vs NNVC Comparison
Compare COCP & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- NNVC
- Stock Information
- Founded
- COCP N/A
- NNVC 2005
- Country
- COCP United States
- NNVC United States
- Employees
- COCP N/A
- NNVC N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- COCP Health Care
- NNVC Health Care
- Exchange
- COCP Nasdaq
- NNVC Nasdaq
- Market Cap
- COCP 20.1M
- NNVC 22.0M
- IPO Year
- COCP N/A
- NNVC N/A
- Fundamental
- Price
- COCP $1.98
- NNVC $1.19
- Analyst Decision
- COCP Strong Buy
- NNVC Strong Buy
- Analyst Count
- COCP 1
- NNVC 1
- Target Price
- COCP $7.00
- NNVC $6.50
- AVG Volume (30 Days)
- COCP 93.7K
- NNVC 622.6K
- Earning Date
- COCP 11-13-2024
- NNVC 02-12-2025
- Dividend Yield
- COCP N/A
- NNVC N/A
- EPS Growth
- COCP N/A
- NNVC N/A
- EPS
- COCP N/A
- NNVC N/A
- Revenue
- COCP N/A
- NNVC N/A
- Revenue This Year
- COCP N/A
- NNVC N/A
- Revenue Next Year
- COCP N/A
- NNVC N/A
- P/E Ratio
- COCP N/A
- NNVC N/A
- Revenue Growth
- COCP N/A
- NNVC N/A
- 52 Week Low
- COCP $1.33
- NNVC $1.01
- 52 Week High
- COCP $3.26
- NNVC $3.59
- Technical
- Relative Strength Index (RSI)
- COCP 44.30
- NNVC 33.37
- Support Level
- COCP $2.21
- NNVC $1.42
- Resistance Level
- COCP $2.60
- NNVC $1.65
- Average True Range (ATR)
- COCP 0.33
- NNVC 0.11
- MACD
- COCP -0.07
- NNVC -0.04
- Stochastic Oscillator
- COCP 4.81
- NNVC 13.21
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.